V09FX03
— Various | Thyroid | Various thyroid diagnostic radiopharmaceuticals
Sodium iodide (131I) is a radioactive compound used in the treatment and diagnosis of thyroid conditions such as hyperthyroidism and thyroid cancer. It emits radiation that destroys overactive or cancerous thyroid cells.
It is administered orally, in capsule or solution form, and is quickly absorbed by the thyroid gland. Treatment with Sodium iodide (131I) is effective and minimally invasive, serving as an alternative to surgical interventions.
Side effects may include dry mouth, fatigue, or inflammation of the salivary glands. As a radioactive compound, its use requires special precautions to minimize radiation exposure.
Consult your doctor to discuss the benefits and risks of treatment with Sodium iodide (131I). It is important to follow all instructions to ensure the safety and effectiveness of the treatment.
General data about IODURA DE SODIU (131I) 0.333 MBq-3.7 MBq 0.333 MBq - 3.7 MBq
Substance:
sodium iodide (131I)
Date of latest medicines list:
01-09-2023
Product code:
W66154001
Strength:
0.333 MBq - 3.7 MBq
Pharmaceutical form:
diagnostic capsules
Quantity:
10
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Marketing authorisation
Manufacturer:
GE HEALTHCARE BUCHLER GMBH & CO. KG - GERMANIA
Holder:
GE HEALTHCARE BUCHLER GMBH & CO. KG - GERMANIA
Number:
5723/2013/01
Shelf life:
5 weeks
Pharmaceutical forms available for sodium iodide (131I)